Gene Therapy Flashcards
Germ line therapy involves…
- Transfection of germ/omnipotent embryonic cell
- Carrier of deleterious allele cured & some gametes
- End of heritability of the disorder
- Genetic changes can go beyond treated individual
- Ethical debate
Somatic gene therapy…
- Targets only the affected body cells
- Therapeutic thresholds differ between disorders
- All affected individuals able to give consent
In vivo gene therapy transfer vector delivered…
In a cell selective manner:
Either
1. Direct tissue injection
2. Receptor-mediated processes
Ex vivo gene therapy involves…
- Tissue removal
- Transfection of cells in culture
- Reimplantation of genetically altered cells
Following ex vivo culture in conditions that stimulate cell proliferation…
Cells exposed to retroviral vector expressing functional cDNA copy of defective gene and then infused back into patient.
In gene-corrected cells, full reconstitution of immune cell compartments is obtained even from…
A few engrafted progenitor cells (may occur without conditioning)
Amount of gene therapies approved in EU & US
EU: 15 (7 cancer, 8 genetic disorders)
US: 16 (8 cancer, 8 genetic disorders)
USA requires approval from local institutional biosafety committee/review board for experiments using…
Transfer of rDNA
After approval of rDNA transfer experiments (by local institutional biosafety committee/review board)
Proposals then considered by rDNA Advisory Committee (RAC) & FDA
Non-therapeutic use of genes/cells/genetic elements/modulation of expression to improve athletic performance
Defined as gene doping by the WADA
Erythropoietin
- Secreted by Kidneys (under hypoxic stress)
- Normal EPO levels = 10mU/ml
Hypoxic stress levels = 10,000mU/ml - EPO gene regulated by Hif1-alpha (TF)
- Recombinant EPO used to treat anaemia (chronic kidney failure/chemotherapy)
- Endogenous EPO is highly glycosylated (40% of total weight)
Isoelectric focusing of rEPO & uEPO
rEPO is much more basic than uEPO
MSTN
A myokine produced and released by myocytes (Inhibit muscle growth)
MSTN mutations result in…
Increased muscle mass (target for muscular Dystrophies)
Rate of homologous recombination can be increased by…
Introducing targeted DNA Ds break
(First done in mammalian cells with target sequence of meganuclease I-SceI)